Abstract
In this study, tissue-engineered skin (TestSkin II) was obtained, separated into its two cellular layers (epidermis and dermis) and DNA was extracted. The first biomarker tested consisted of screening for DNA point mutations in the p53 gene, the most commonly mutated gene in skin cancer. To ensure the accuracy of the results, two measurement technologies that incorporate internal calibration standards were used. It was shown that tissue-engineered skin did not contain mutations in this gene at the level of sensitivity of capillary electrophoresis-SSCP and Denaturing High Performance Liquid Chromatography. Results were compared to control cells (neonatal fibroblasts and neonatal keratinocytes) and fibroblasts that were obtained from a 55 year-old and 96 year-old human donor. The second set of biomarkers tested looked at the loss of the Y-chromosome. Using Fluorescent In Situ Hybridization technology, Y chromosome loss was examined in the tissue-engineered skin, normal control lymphocytes, and neonatal and aged (55 and 96 year-old) donor control cells. Y-chromosome loss was only detected in the fibroblasts from the 96 year-old donor. Biomarkers such as p53 mutations and chromosome loss can provide the basis for an international reference standard of cellular biomarkers to aid in the development and safety of tissue engineered medical products.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hussain, S.P., Hofseth, L.J., and Harris, C.C., 2001, Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment.Lung Cancer34, S7–15.
Whittaker, S., 2001, Molecular genetics of cutaneous lymphomas.Ann. N. Y. Acad. Sci. 94139–45.
Stone, J.F., and Sandberg, A.A., 1995, Sex chromosome aneuploidy and aging.Mutat. Res. 338107–113.
Cotton, R.G., 2000, Methods in clinical molecular genetics.Eur. J. Pediatr. 159S179–S182.
O’Connell, C.D., Tian, J., Juhasz, A., Wenz, H.M., and Atha, D.H., 1998, Development of standard reference materials for diagnosis of p53 mutations: analysis by slab gel single strand conformation polymorphism.Electrophoresis 19164–171.
Atha, D.H., Wenz, H.M., Morehead, H., Tian, J., and O’Connell, C.D., 1998, Detection of p53 point mutations by single strand conformation polymorphism: analysis by capillary electrophoresis.Electrophoresis 19172–179.
Barch, M., Knutsen, T., and Spurbeck, J., 1997The AGT Cytogenetics Laboratory Manual3rd ed., Lippincott-Raven Publishing, New York.
Barker, P.E., and Schwab, M., 1993, Junction mapping of translocation chromosomes by fluorescencein situhybridization (FISH) and computer image analysis in human solid tumors.Methods in Molecular Genetics 2129–154.
Keller, G., Hartmann, A., Mueller, J., and Hofler, H., 2001, Denaturing high pressure liquid chromatography (DHPLC) for the analysis of somatic p53 mutations.Lab. Invest. 811735–1737.
O’Connell, C.D., Tully, L., Devaney, J., Marino, M., Jakupciak, J.P., and Atha, D.H. A standard reference material for the detection of p53 mutations. Manuscript in preparation.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
O’Connell, C. et al. (2003). Biomarkers Used to Detect Genetic Damage in Tissue Engineered Skin. In: Elçin, Y.M. (eds) Tissue Engineering, Stem Cells, and Gene Therapies. Advances in Experimental Medicine and Biology, vol 534. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0063-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0063-6_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4907-5
Online ISBN: 978-1-4615-0063-6
eBook Packages: Springer Book Archive